Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation
- Wednesday, June 21, 2023, 7:02
- Finance
- Add a comment
Research to Confirm the Hemopurifier’s Ability to Remove Harmful Viruses and Exosomes From Harvested Organs SAN DIEGO, June 21, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening…
About the Author
adminasapcorp has written 41546 stories on this site.